warning icon

COVID-19 DEW Report, powered by Reformulary®Click here

X

Latest From the
world of Reformulary

Reformulary Group launches COVID-19 DEW Report
 
Learn More
New study underscores importance of medical cannabis rating system
 
Learn More
Reformulary 2019 Year in Review
 
Learn More
Cannabis Standard Insights, Issue #2 published by Reformulary Group
 
Learn More
CIX Canadian Innovation Exchange announced Reformulary Group as a CIX TOP 20 Early innovative Canad...
 
Learn More
Letter to the editor: Pharmacare – not all Canadians, not all drugs
 
Learn More
The challenges with medical cannabis in the workplace
 
Learn More
Reformulary Group creates online community platform for info on medical cannabis
 
Learn More
Reformulary Group launches medical cannabis formulary
 
Learn More
Reformulary 2018 Year in Review
 
Learn More
Canada’s first evidence-based medical cannabis formulary launches
 
Learn More
The Reformulary, now available through Great-West Life
 
Learn More